These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2132570)

  • 1. Advances in macrocyclic gadolinium complexes as magnetic resonance imaging contrast agents.
    Meyer D; Schaefer M; Doucet D
    Invest Radiol; 1990 Sep; 25 Suppl 1():S53-5. PubMed ID: 2132570
    [No Abstract]   [Full Text] [Related]  

  • 2. Tolerance of extracellular contrast agents for magnetic resonance imaging.
    Weinmann HJ; Press WR; Gries H
    Invest Radiol; 1990 Sep; 25 Suppl 1():S49-50. PubMed ID: 2283256
    [No Abstract]   [Full Text] [Related]  

  • 3. Neurotoxicity of contrast media for magnetic resonance imaging after generalized breakdown of the blood-brain barrier.
    Evill CA; Wilson AJ; Fletcher MC; Sage MR
    Acad Radiol; 1996 Aug; 3 Suppl 2():S336-8. PubMed ID: 8796597
    [No Abstract]   [Full Text] [Related]  

  • 4. Paramagnetic liposomes as magnetic resonance contrast agents.
    Unger E; Tilcock C; Ahkong QF; Fritz T
    Invest Radiol; 1990 Sep; 25 Suppl 1():S65-6. PubMed ID: 2283260
    [No Abstract]   [Full Text] [Related]  

  • 5. Extravascular toxicity of two magnetic resonance contrast agents. Preliminary experience in the rat.
    Cohan RH; Leder RA; Herzberg AJ; Hedlund LW; Wheeler CT; Beam CA; Nadel SN; Dunnick NR
    Invest Radiol; 1991 Mar; 26(3):224-6. PubMed ID: 2055727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging contrast enhancement versus tissue gadolinium concentration.
    Wang SC; White DL; Pope JM; Brasch RC
    Invest Radiol; 1990 Sep; 25 Suppl 1():S44-5. PubMed ID: 2283253
    [No Abstract]   [Full Text] [Related]  

  • 7. The synthesis and screening of nonionic gadolinium (III) DTPA-bisamide complexes as magnetic resonance imaging contrast agents.
    Periasamy M; White D; deLearie L; Moore D; Wallace R; Lin W; Dunn J; Hirth W; Cacheris W; Pilcher G
    Invest Radiol; 1991 Nov; 26 Suppl 1():S217-20; discussion S232-5. PubMed ID: 1667003
    [No Abstract]   [Full Text] [Related]  

  • 8. Quantification of capillary permeability to macromolecular magnetic resonance imaging contrast media in experimental mammary adenocarcinomas.
    Brasch RC; Shames DM; Cohen FM; Kuwatsuru R; Neuder M; Mann JS; Vexler V; Mühler A; Rosenau W
    Invest Radiol; 1994 Jun; 29 Suppl 2():S8-11. PubMed ID: 7928277
    [No Abstract]   [Full Text] [Related]  

  • 9. Theory of proton relaxation in solutions of magnetic nanoparticles, including the superparamagnetic size range.
    Koenig SH; Kellar KE
    Acad Radiol; 1996 Aug; 3 Suppl 2():S273-6. PubMed ID: 8796579
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety of magnetic resonance imaging contrast agents.
    Shellock FG; Kanal E
    J Magn Reson Imaging; 1999 Sep; 10(3):477-84. PubMed ID: 10508312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging enhanced with a macromolecular contrast agent. Detection of the zonal renal ischemia.
    Vexler VS; Berthezene Y; Moseley ME; Brasch RC
    Invest Radiol; 1991 Nov; 26 Suppl 1():S131-3; discussion S137-8. PubMed ID: 1808109
    [No Abstract]   [Full Text] [Related]  

  • 12. Rationale and applications for macromolecular Gd-based contrast agents.
    Brasch RC
    Magn Reson Med; 1991 Dec; 22(2):282-7; discussion 300-3. PubMed ID: 1725917
    [No Abstract]   [Full Text] [Related]  

  • 13. Magnetic resonance imaging contrast agents. Design and physicochemical properties of gadodiamide.
    Chang CA
    Invest Radiol; 1993 Mar; 28 Suppl 1():S21-7. PubMed ID: 8486500
    [No Abstract]   [Full Text] [Related]  

  • 14. The need for electron paramagnetic resonance and water exchange-rate data for understanding small magnetic resonance imaging contrast agents and their macromolecular complexes.
    Koenig SH
    Invest Radiol; 1994 Jun; 29 Suppl 2():S127-30. PubMed ID: 7928207
    [No Abstract]   [Full Text] [Related]  

  • 15. Experimental approach to the intra-arterial magnetic resonance imaging contrast media (Gd-DTPA-iodized oil) and new lipophilic gadolinium complex combined with iodized oil.
    Yoshikawa K; Shiono T; Yamashita T; Iwai H; Abe O; Hisamatsu K; Takenaka E
    Invest Radiol; 1994 Jun; 29 Suppl 2():S245-6. PubMed ID: 7928246
    [No Abstract]   [Full Text] [Related]  

  • 16. Spatial mapping of microvascular permeability and tissue blood volume using magnetic resonance imaging.
    Demsar F; Roberts TP; Schwickert HC; Shames DM; van Dijke CF; Mann JS; Saeed M; Brasch RC
    Acad Radiol; 1996 Aug; 3 Suppl 2():S344-6. PubMed ID: 8796599
    [No Abstract]   [Full Text] [Related]  

  • 17. The question of dose for gadolinium chelates in magnetic resonance imaging.
    Runge VM; Kirsch JE; Wells JW; Dunworth JN; Woolfolk CE
    Invest Radiol; 1994 Jun; 29 Suppl 2():S154-6. PubMed ID: 7928215
    [No Abstract]   [Full Text] [Related]  

  • 18. Brain distribution of MRI contrast media in rats after intracisternal injection.
    Allard M; Kien P; Caille JM; Bonnemain B; Simonnet G
    J Neuroradiol; 1987; 14(4):383-7. PubMed ID: 3131496
    [No Abstract]   [Full Text] [Related]  

  • 19. Experimental study of DOTA-gadolinium. Pharmacokinetics and pharmacologic properties.
    Allard M; Doucet D; Kien P; Bonnemain B; Caillé JM
    Invest Radiol; 1988 Sep; 23 Suppl 1():S271-4. PubMed ID: 3198361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gadolinium cryptelates as MR contrast agents.
    Knop RH; Frank JA; Dwyer AJ; Girton ME; Naegele M; Schrader M; Cobb J; Gansow O; Maegerstadt M; Brechbiel M
    J Comput Assist Tomogr; 1987; 11(1):35-42. PubMed ID: 3805426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.